Morgan Stanley’s Shockwave Medical SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-446,611
Closed -$145M – 8018
2024
Q1
$145M Buy
446,611
+45,226
+11% +$11.1M 0.01% 950
2023
Q4
$76.5M Sell
401,385
-29,110
-7% -$5.5M 0.01% 1352
2023
Q3
$85.7M Buy
430,495
+14,164
+3% +$3.35M 0.01% 1161
2023
Q2
$119M Buy
416,331
+25,701
+7% +$7.14M 0.01% 984
2023
Q1
$84.7M Buy
390,630
+109,362
+39% +$21.3M 0.01% 1163
2022
Q4
$57.8M Sell
281,268
-77,808
-22% -$19.7M 0.01% 1384
2022
Q3
$100M Buy
359,076
+103,019
+40% +$26.2M 0.01% 890
2022
Q2
$49M Buy
256,057
+63,763
+33% +$11.3M 0.01% 1375
2022
Q1
$39.9M Sell
192,294
-237,909
-55% -$39.2M 0.01% 1466
2021
Q4
$76.7M Sell
430,203
-46,683
-10% -$9.21M 0.01% 1054
2021
Q3
$98.2M Buy
476,886
+122,483
+35% +$24M 0.01% 858
2021
Q2
$67.2M Buy
354,403
+188,626
+114% +$30.9M 0.01% 1109
2021
Q1
$21.6M Sell
165,777
-206,078
-55% -$24.7M ﹤0.01% 1837
2020
Q4
$38.6M Buy
371,855
+213,548
+135% +$18.5M 0.01% 1291
2020
Q3
$12M Sell
158,307
-425,345
-73% -$24.1M ﹤0.01% 1881
2020
Q2
$27.6M Buy
583,652
+248,214
+74% +$10.2M 0.01% 1186
2020
Q1
$11.1M Sell
335,438
-19,480
-5% -$774K ﹤0.01% 1682
2019
Q4
$15.6M Buy
354,918
+22,934
+7% +$847K ﹤0.01% 1897
2019
Q3
$9.9M Buy
331,984
+62,257
+23% +$2.64M ﹤0.01% 2138
2019
Q2
$15.4M Buy
269,727
+37,647
+16% +$1.83M ﹤0.01% 1726
2019
Q1
$7.77M Buy
+232,080
New +$7.71M ﹤0.01% 2291

Other funds holding SWAV

Morgan Stanley's SWAV Position: Q2 2024 in Review

Morgan Stanley sold out of Shockwave Medical (SWAV) in Q2 2024, closing a stake of 446,611 shares — an estimated $145M sold.

Morgan Stanley first reported a position in SWAV in Q1 2019 and held it in 21 quarters. The position peaked at $145M in Q1 2024. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Morgan Stanley reported no remaining Shockwave Medical position as of Q2 2024 after selling out during the quarter.
  • Morgan Stanley sold 446,611 Shockwave Medical shares in Q2 2024, an estimated $145M.
  • Morgan Stanley first reported a position in Shockwave Medical in Q1 2019 and held it in 21 quarters.
  • Morgan Stanley's Shockwave Medical position peaked at $145M in Q1 2024.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical as of Q2 2024.

Based on Morgan Stanley's 13F filing for Q2 2024, filed 14 Aug 2024.